Skip to main content
Top
Published in: CEN Case Reports 2/2020

01-05-2020 | Nephrectomy | Case Report

Vaginal bleeding as primary presentation of renal cell carcinoma

Authors: Asaad Moradi, Behnam Shakiba, Robab Maghsoudi, Reza Dehghaniathar

Published in: CEN Case Reports | Issue 2/2020

Login to get access

Abstract

Vaginal metastases from renal cell carcinoma has been recorded as extremely rare. We present a patient with vaginal bleeding as primary manifestation of renal cell carcinoma. A 40-year-old woman presented to a local private clinic with intermittent vaginal bleeding for approximately one month. Gynecological examination revealed a mass on the vaginal wall at approximately 8 o’clock. She underwent dilation and curettage (D&C) and mass excision. Microscopic histopathology and immunohistochemical stains showed vaginal metastases of clear cell RCC. The patient was referred to our urology clinic. Magnetic Resonance Imaging (MRI) of abdomen and pelvic showed a well-defined solid mass lesion measuring 16 × 12 × 11 cm in left kidney. Patient underwent left side radical nephrectomy through a left subcostal intraperitoneal incision. Histopathological results and metastasis workup confirmed the diagnosis of RCC with solitary metastatic vaginal lesion. After radical nephrectomy, she was treated with Sunitinib. No local relapse or distant metastasis was recognized 5 months after radical nephrectomy. In conclusion, the incidence of RCC metastasis to the vagina is extremely rare; but, in cases of vaginal bleeding or lesions we have to keep in mind the possibility of metastatic RCC.
Literature
1.
go back to reference Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Grünwald V, Gillessen S, Horwich A, ESMO Guidelines Committee. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(5):706–20.CrossRef Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Grünwald V, Gillessen S, Horwich A, ESMO Guidelines Committee. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(5):706–20.CrossRef
2.
go back to reference Ozturk H. Bilateral synchronous adrenal metastases of renal cell carcinoma: a case report and review of the literature. Oncol Lett. 2015;9:1897–901.CrossRef Ozturk H. Bilateral synchronous adrenal metastases of renal cell carcinoma: a case report and review of the literature. Oncol Lett. 2015;9:1897–901.CrossRef
3.
go back to reference Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.CrossRef Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.CrossRef
4.
go back to reference Pisavadia B, Mevcha A, Patel D, Sinha B, Blacker ARJ, et al. Case report: an unusual presentation of metastatic renal cell carcinoma with per-vaginal bleeding. Urol Nephrol Open Access J. 2017;4(2):00118. Pisavadia B, Mevcha A, Patel D, Sinha B, Blacker ARJ, et al. Case report: an unusual presentation of metastatic renal cell carcinoma with per-vaginal bleeding. Urol Nephrol Open Access J. 2017;4(2):00118.
5.
go back to reference Brufau BP, Cerqueda CS, Villalba LB, Izquierdo RS, González BM, Molina CN. Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics. 2013;33(6):1691–716.CrossRef Brufau BP, Cerqueda CS, Villalba LB, Izquierdo RS, González BM, Molina CN. Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics. 2013;33(6):1691–716.CrossRef
6.
go back to reference Kharmoum J, Kharmoum S, Bellarbi S. Vaginal metastasis of renal cell carcinoma: a case report. Pan Arab J Oncol. 2014;7:40–2. Kharmoum J, Kharmoum S, Bellarbi S. Vaginal metastasis of renal cell carcinoma: a case report. Pan Arab J Oncol. 2014;7:40–2.
7.
go back to reference Peham I. Hypernephrom der linken Niere mitein er Metastase in der Vagina. Zentralbl Gynak Ol. 1906;30:724–5. Peham I. Hypernephrom der linken Niere mitein er Metastase in der Vagina. Zentralbl Gynak Ol. 1906;30:724–5.
8.
go back to reference Chibuzo lN, Takure AO, Adebayo SA, Shittu OB. Synchronous vulvar and vaginal metastasis from a type II papillary renal cell carcinoma—a case report. J Urol Res. 2016;3(2):1047. Chibuzo lN, Takure AO, Adebayo SA, Shittu OB. Synchronous vulvar and vaginal metastasis from a type II papillary renal cell carcinoma—a case report. J Urol Res. 2016;3(2):1047.
10.
go back to reference Benbrahim Z, Chouaib A, Mazeron R, Leger-Ravet MB, Lefort C, Lhommé C, El Mesbahi O, Escudier B. Gynecologic bleeding revealing vaginal metastasis of renal cell carcinoma. Pan Afr Med J. 2013;14:62.PubMedPubMedCentral Benbrahim Z, Chouaib A, Mazeron R, Leger-Ravet MB, Lefort C, Lhommé C, El Mesbahi O, Escudier B. Gynecologic bleeding revealing vaginal metastasis of renal cell carcinoma. Pan Afr Med J. 2013;14:62.PubMedPubMedCentral
11.
go back to reference Sun DQ, Lu JJ, Cao QW, Zhang H, Tian YJ, Bi DB, Ding ST. Metastatic renal cell carcinoma to vagina and review of literature. Chin Med J (Engl). 2013;126(9):1793. Sun DQ, Lu JJ, Cao QW, Zhang H, Tian YJ, Bi DB, Ding ST. Metastatic renal cell carcinoma to vagina and review of literature. Chin Med J (Engl). 2013;126(9):1793.
12.
go back to reference Mulcahy JJ, Furlow WL. Vaginal metastasis from renal cell carcinoma: radiographic evidence of possible route of spread. J Urol. 1970;104(1):50–2.CrossRef Mulcahy JJ, Furlow WL. Vaginal metastasis from renal cell carcinoma: radiographic evidence of possible route of spread. J Urol. 1970;104(1):50–2.CrossRef
13.
go back to reference Schmid TA, Gore ME. Sunitinib in the treatment of metastatic renal cell carcinoma. Ther Adv Urol. 2016;8(6):348–71.CrossRef Schmid TA, Gore ME. Sunitinib in the treatment of metastatic renal cell carcinoma. Ther Adv Urol. 2016;8(6):348–71.CrossRef
Metadata
Title
Vaginal bleeding as primary presentation of renal cell carcinoma
Authors
Asaad Moradi
Behnam Shakiba
Robab Maghsoudi
Reza Dehghaniathar
Publication date
01-05-2020
Publisher
Springer Singapore
Published in
CEN Case Reports / Issue 2/2020
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-019-00442-z

Other articles of this Issue 2/2020

CEN Case Reports 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine